Cargando…

FXYD proteins and sodium pump regulatory mechanisms

The sodium/potassium-ATPase (NKA) is the enzyme that establishes gradients of sodium and potassium across the plasma membrane. NKA activity is tightly regulated for different physiological contexts through interactions with single-span transmembrane peptides, the FXYD proteins. This diverse family o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yap, John Q., Seflova, Jaroslava, Sweazey, Ryan, Artigas, Pablo, Robia, Seth L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953255/
https://www.ncbi.nlm.nih.gov/pubmed/33688925
http://dx.doi.org/10.1085/jgp.202012633
_version_ 1783663880520597504
author Yap, John Q.
Seflova, Jaroslava
Sweazey, Ryan
Artigas, Pablo
Robia, Seth L.
author_facet Yap, John Q.
Seflova, Jaroslava
Sweazey, Ryan
Artigas, Pablo
Robia, Seth L.
author_sort Yap, John Q.
collection PubMed
description The sodium/potassium-ATPase (NKA) is the enzyme that establishes gradients of sodium and potassium across the plasma membrane. NKA activity is tightly regulated for different physiological contexts through interactions with single-span transmembrane peptides, the FXYD proteins. This diverse family of regulators has in common a domain containing a Phe-X-Tyr-Asp (FXYD) motif, two conserved glycines, and one serine residue. In humans, there are seven tissue-specific FXYD proteins that differentially modulate NKA kinetics as appropriate for each system, providing dynamic responsiveness to changing physiological conditions. Our understanding of how FXYD proteins contribute to homeostasis has benefitted from recent advances described in this review: biochemical and biophysical studies have provided insight into regulatory mechanisms, genetic models have uncovered remarkable complexity of FXYD function in integrated physiological systems, new posttranslational modifications have been identified, high-resolution structural studies have revealed new details of the regulatory interaction with NKA, and new clinical correlations have been uncovered. In this review, we address the structural determinants of diverse FXYD functions and the special roles of FXYDs in various physiological systems. We also discuss the possible roles of FXYDs in protein trafficking and regulation of non-NKA targets.
format Online
Article
Text
id pubmed-7953255
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-79532552021-10-05 FXYD proteins and sodium pump regulatory mechanisms Yap, John Q. Seflova, Jaroslava Sweazey, Ryan Artigas, Pablo Robia, Seth L. J Gen Physiol Review The sodium/potassium-ATPase (NKA) is the enzyme that establishes gradients of sodium and potassium across the plasma membrane. NKA activity is tightly regulated for different physiological contexts through interactions with single-span transmembrane peptides, the FXYD proteins. This diverse family of regulators has in common a domain containing a Phe-X-Tyr-Asp (FXYD) motif, two conserved glycines, and one serine residue. In humans, there are seven tissue-specific FXYD proteins that differentially modulate NKA kinetics as appropriate for each system, providing dynamic responsiveness to changing physiological conditions. Our understanding of how FXYD proteins contribute to homeostasis has benefitted from recent advances described in this review: biochemical and biophysical studies have provided insight into regulatory mechanisms, genetic models have uncovered remarkable complexity of FXYD function in integrated physiological systems, new posttranslational modifications have been identified, high-resolution structural studies have revealed new details of the regulatory interaction with NKA, and new clinical correlations have been uncovered. In this review, we address the structural determinants of diverse FXYD functions and the special roles of FXYDs in various physiological systems. We also discuss the possible roles of FXYDs in protein trafficking and regulation of non-NKA targets. Rockefeller University Press 2021-03-10 /pmc/articles/PMC7953255/ /pubmed/33688925 http://dx.doi.org/10.1085/jgp.202012633 Text en © 2021 Yap et al. http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Review
Yap, John Q.
Seflova, Jaroslava
Sweazey, Ryan
Artigas, Pablo
Robia, Seth L.
FXYD proteins and sodium pump regulatory mechanisms
title FXYD proteins and sodium pump regulatory mechanisms
title_full FXYD proteins and sodium pump regulatory mechanisms
title_fullStr FXYD proteins and sodium pump regulatory mechanisms
title_full_unstemmed FXYD proteins and sodium pump regulatory mechanisms
title_short FXYD proteins and sodium pump regulatory mechanisms
title_sort fxyd proteins and sodium pump regulatory mechanisms
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953255/
https://www.ncbi.nlm.nih.gov/pubmed/33688925
http://dx.doi.org/10.1085/jgp.202012633
work_keys_str_mv AT yapjohnq fxydproteinsandsodiumpumpregulatorymechanisms
AT seflovajaroslava fxydproteinsandsodiumpumpregulatorymechanisms
AT sweazeyryan fxydproteinsandsodiumpumpregulatorymechanisms
AT artigaspablo fxydproteinsandsodiumpumpregulatorymechanisms
AT robiasethl fxydproteinsandsodiumpumpregulatorymechanisms